Big Data Analytics in Oncology with R
portes grátis
Big Data Analytics in Oncology with R
Bhattacharjee, Atanu
Taylor & Francis Ltd
12/2022
254
Dura
Inglês
9781032028767
15 a 20 dias
657
Descrição não disponível.
1. Survival Analysis. 2. Cox Proportional Survival Analysis. 3. Parametric Survival Analysis. 4. Competing Risk Modeling in High Dimensional Data. 5. Biomarker Thresholding in High Dimensional Data. 6. High Dimensional Survival Data Analysis. 7. Frailty Models. 8. Time-Course Gene Expression Data Analysis. 9. Survival Analysis and Time-course Data Analysis. 10. Features Selection in High Dimensional Time to Event Data
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Bayesian;Gene;Oncology;Data;High Dimensional Data;Hazard Function;Cox PH Model;Cox Proportional Hazard Model;High Dimensional Gene Expression Data;Frailty Model;Cox Model;Survival Analysis;Cox PH;Kaplan Meier Estimator;Brier Score;Expression Values;CPH;Survival Duration;Lasso;Optimal Threshold Levels;Cart Analysis;Protein Expression Values;Frailty Distribution;Bayesian State Space;Increased Fold Change;Competing Risk Scenario;Prognostic Biomarker;Correlated Frailty Models;Roc Curve
1. Survival Analysis. 2. Cox Proportional Survival Analysis. 3. Parametric Survival Analysis. 4. Competing Risk Modeling in High Dimensional Data. 5. Biomarker Thresholding in High Dimensional Data. 6. High Dimensional Survival Data Analysis. 7. Frailty Models. 8. Time-Course Gene Expression Data Analysis. 9. Survival Analysis and Time-course Data Analysis. 10. Features Selection in High Dimensional Time to Event Data
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Bayesian;Gene;Oncology;Data;High Dimensional Data;Hazard Function;Cox PH Model;Cox Proportional Hazard Model;High Dimensional Gene Expression Data;Frailty Model;Cox Model;Survival Analysis;Cox PH;Kaplan Meier Estimator;Brier Score;Expression Values;CPH;Survival Duration;Lasso;Optimal Threshold Levels;Cart Analysis;Protein Expression Values;Frailty Distribution;Bayesian State Space;Increased Fold Change;Competing Risk Scenario;Prognostic Biomarker;Correlated Frailty Models;Roc Curve
